Trial · NCT00770653
Results by group64
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 64
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Mean Increase From Baseline in High-Density Lipoprotein Cholesterol. | Pioglitazone 15 mg and Metformin 850 mg BID | 3.2 | Standard Error 9.7 | mg/dL | |
| The Mean Increase From Baseline in High-Density Lipoprotein Cholesterol. | Glimepiride 2 mg and Metformin 850 mg BID | -0.3 | Standard Error 11.0 | mg/dL | |
| Change From Baseline in High-Density Lipoprotein Cholesterol. | Pioglitazone 15 mg and Metformin 850 mg BID | 3.3 | Standard Error 9.6 | mg/dL | |
| Change From Baseline in High-Density Lipoprotein Cholesterol. | Glimepiride 2 mg and Metformin 850 mg BID | -0.4 | Standard Error 11.1 | mg/dL | |
| Change From Baseline in High-Density Lipoprotein/Low-Density Lipoprotein Ratio. | Pioglitazone 15 mg and Metformin 850 mg BID | 0.1 | Standard Error 0.8 | mg/dL | |
| Change From Baseline in High-Density Lipoprotein/Low-Density Lipoprotein Ratio. | Glimepiride 2 mg and Metformin 850 mg BID | 0.3 | Standard Error 0.7 | mg/dL | |
| Change From Baseline in Triglycerides. | Pioglitazone 15 mg and Metformin 850 mg BID | -40.9 | Standard Error 113.8 | mg/dL | |
| Change From Baseline in Triglycerides. | Glimepiride 2 mg and Metformin 850 mg BID | -16.7 | Standard Error 121.6 | mg/dL | |
| Change From Baseline in Low-Density Lipoprotein Subfractions. | Pioglitazone 15 mg and Metformin 850 mg BID | 6.2 | Standard Error 17.5 | mg/dL | |
| Change From Baseline in Low-Density Lipoprotein Subfractions. | Glimepiride 2 mg and Metformin 850 mg BID | 6.1 | Standard Error 26.4 | mg/dL | |
| Change From Baseline in Low-Density Lipoprotein Cholesterol. | Pioglitazone 15 mg and Metformin 850 mg BID | 9.7 | Standard Error 34.7 | mg/dL | |
| Change From Baseline in Low-Density Lipoprotein Cholesterol. | Glimepiride 2 mg and Metformin 850 mg BID | 11.2 | Standard Error 25.3 | mg/dL | |
| Change From Baseline in Glycosylated Hemoglobin. | Pioglitazone 15 mg and Metformin 850 mg BID | -0.83 | Standard Error 0.87 | mg/dL | |
| Change From Baseline in Glycosylated Hemoglobin. | Glimepiride 2 mg and Metformin 850 mg BID | -0.95 | Standard Error 0.85 | mg/dL | |
| Change From Baseline in Fasting Intact Proinsulin. | Pioglitazone 15 mg and Metformin 850 mg BID | -5.18 | Standard Error 11.89 | pmol/L | |
| Change From Baseline in Fasting Intact Proinsulin. | Glimepiride 2 mg and Metformin 850 mg BID | -0.11 | Standard Error 9.84 | pmol/L | |
| Change From Baseline in Fasting Glucose. | Pioglitazone 15 mg and Metformin 850 mg BID | -21.6 | Standard Error 38.6 | mg/dL | |
| Change From Baseline in Fasting Glucose. | Glimepiride 2 mg and Metformin 850 mg BID | -21.1 | Standard Error 40.4 | mg/dL | |
| Change From Baseline in Adiponectin. | Pioglitazone 15 mg and Metformin 850 mg BID | 6.79 | Standard Error 6.38 | μg/mL | |
| Change From Baseline in Adiponectin. | Glimepiride 2 mg and Metformin 850 mg BID | 0.72 | Standard Error 2.73 | μg/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00770653/results